Drug intelligence / Profile preview

Qingfei Huayu Decoction

Development stage: Preclinical
Lead developer: Shuguang Hospital
Administration: Oral

Overview

Qingfei Huayu Decoction is a traditional Chinese medicine used in the treatment of pulmonary fibrosis, particularly in patients with rheumatoid arthritis-related pulmonary interstitial disease. It is part of an interventional study aimed at assessing its efficacy in improving pulmonary function and reducing symptoms associated with lung heat and blood stasis syndrome[1].

Beyond the preview

Go deeper on Qingfei Huayu Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingfei Huayu Decoction.

Explore the full profile